EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Head‐and‐neck dermatofibrosarcoma protuberans: Survival analysis and Clinically relevant immunohistochemical indicators

Zhenlin Dai, Youya He, Xu Zhang, Zhen Tian iD, Guopei Zhu, Zhenhu Ren, Lulu Ye, Zheqi Liu, Chunyue Ma iD, Wei Cao iD, Tong Ji iD

Oral Diseases · 2024

DOI: 10.1111/odi.14495 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oral Diseases, 2024. Verfasst von Zhenlin Dai und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial-Head and Neck Oncology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Chi…. Hauptthemen laut MEDLINE: Dermatofibrosarcoma, Head and Neck Neoplasms, Skin Neoplasms, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Clinical Research Project of Multi-Disciplinary Team, Shanghai Ninth People's Hospital, Shanghai University School of Medicine, National Natural Science Foundation of China, Biobank Program of Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Head and neck dermatofibrosarcoma protuberans (HNDFSP) is extremely rare and not entirely understood.

Objective

To investigate the clinicopathological features of HNDFSP and identify the expression of its clinically relevant indicators, with the expectation of improving the existing treatment strategies.

Methods

A long‐term follow‐up of patients with HNDFSP who received treatment between 2000 and 2021 at Shanghai Ninth People's Hospital was conducted. The clinical, histological, and immunohistochemical data of the patients were retrieved and analyzed. The endpoint of the study was the incidence of significant disease‐related clinical events (recurrences or metastasis).

Results

A total of 49 patients with HNDFSP were included in the study, with males (92.7%) predominating than females (7.3%). Eighteen patients developed recurrent disease (36.8%) after surgery, and the median time of recurrence was 48 months (interquartile, 20–74 months). Metastasis occurred in two cases (4.1%). Two patients died during follow‐up, both with local recurrence, and one of them with intestinal metastasis. Post‐operation radiotherapy was administered to eight patients (16.3%) and the effect in local control was remarkable. Age, tumor size, and negative margins with sufficient safety width were the main independent factors affecting the disease‐free survival. Several potential targeted therapeutic indicators, including EZH2 (80.0%), EGFR (91.4%), PDGF (97.1%), PD‐L1 (77.1%), and VEGF (77.1%), were positively expressed in most tumor samples.

Conclusion

HNDFSP is rare, significantly challenging to control locally, and has a worse prognosis with current treatment strategies. Wide local excision and long‐term follow‐up are needed. Radiotherapy could improve the prognosis of patients with HNDFSP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DermatofibrosarcomaHead and Neck NeoplasmsSkin NeoplasmsNeoplasm Recurrence, LocalHumansMaleFemaleMiddle AgedAdultB7-H1 AntigenErbB ReceptorsYoung AdultImmunohistochemistrySurvival AnalysisAgedVascular Endothelial Growth Factor AAdolescentBiomarkers, TumorEnhancer of Zeste Homolog 2 Protein

Stichwörter der Autor:innen

dermatofibrosarcoma protuberanshead and neck neoplasmradiotherapysurgical resectiontherapeutic indicators

Substanzen

B7-H1 AntigenErbB ReceptorsVascular Endothelial Growth Factor ACD274 protein, humanEGFR protein, humanBiomarkers, TumorEnhancer of Zeste Homolog 2 Protein

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial-Head and Neck Oncology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Shanghai Key Laboratory of Stomatology, Shanghai Research Institute of Stomatology, Shanghai, China.
  • National Clinical Research Center for Oral Disease, Shanghai, China.
  • Department of Oral Pathology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

ORCID-Profile: Zhen Tian, Chunyue Ma, Wei Cao, Tong Ji

Förderung

  • Clinical Research Project of Multi-Disciplinary Team, Shanghai Ninth People's Hospital, Shanghai University School of Medicine
  • National Natural Science Foundation of China
  • Biobank Program of Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine

Zitieren

APA

Dai, Z., He, Y., Zhang, X., Tian, Z., Zhu, G., Ren, Z., Ye, L., Liu, Z., Ma, C., Cao, W., & Ji, T. (2024). Head‐and‐neck dermatofibrosarcoma protuberans: Survival analysis and Clinically relevant immunohistochemical indicators. Oral Diseases. https://doi.org/10.1111/odi.14495

Vancouver

Dai Z, He Y, Zhang X, Tian Z, Zhu G, Ren Z, et al. Head‐and‐neck dermatofibrosarcoma protuberans: Survival analysis and Clinically relevant immunohistochemical indicators. Oral Diseases. 2024. doi:10.1111/odi.14495

BibTeX
@article{Dai2024,
  author = {Dai, Zhenlin and He, Youya and Zhang, Xu and Tian, Zhen and Zhu, Guopei and Ren, Zhenhu and Ye, Lulu and Liu, Zheqi and Ma, Chunyue and Cao, Wei and Ji, Tong},
  title = {Head‐and‐neck dermatofibrosarcoma protuberans: Survival analysis and Clinically relevant immunohistochemical indicators},
  journal = {Oral Diseases},
  year = {2024},
  doi = {10.1111/odi.14495}
}
Kostenlos starten →